Talia Helman

University of Central Florida, Emory Healthcare

Papers

5

Total Citations

33

H-Index

4

About

Talia Helman is a urologic surgeon and researcher whose work centers on robotic-assisted surgery for prostate cancer and benign prostatic hyperplasia (BPH). Her major contributions focus on optimizing surgical outcomes and cost-effectiveness in robotic-assisted radical prostatectomy (RARP). In her highly cited 2022 study, she investigated whether the type of robotic platform—comparing multi-port and single-port systems—affects the final cost of RARP, providing crucial data for hospital resource allocation. Helman has also pioneered minimally invasive techniques for managing post-surgical complications, notably developing a step-by-step approach for lymphocele drainage using the Da Vinci® single-port platform. Her work on this technique, published in 2021 and 2022, has been cited over 17 times and offers a permanent, minimally invasive solution for a complication affecting up to half of prostate cancer patients after pelvic lymph node dissection. Additionally, her 2024 paper on advances in outpatient therapies for BPH expands her expertise into non-surgical management. With over 30 total citations, Helman is establishing herself as a leader in refining robotic urologic procedures to improve patient outcomes and reduce healthcare costs.

Research Focus

Key Achievements

4
H-Index
5
Papers
33
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Does type of robotic platform make a difference in the final cost of robotic-assisted radical prostatectomy?
10 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of Central Florida, Emory Healthcare

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago